Overview
African trypanosomiasis, also known as sleeping sickness, can involve cutaneous manifestations due to Trypanosoma brucei gambiense or rhodesiense. Skin involvement often presents as localized or diffuse lesions, reflecting systemic infection and potentially indicating disease progression 1.Diagnosis
Clinical Presentation: Skin lesions may include ulcers, nodules, or diffuse rashes 1.
Laboratory Tests: Blood smear for trypanosomes, serological tests (ELISA, CATT, LiTat), and cerebrospinal fluid analysis if central nervous system involvement is suspected 1.
Grading: Not specifically detailed for cutaneous manifestations; staging typically focuses on neurological involvement (hemolymphatic vs. meningoencephalitic stages) 1.Management
First-Line Treatment: Pentamidine for initial hemolymphatic stage followed by eflornithine or nifurtimox, depending on the subspecies (T. b. gambiense vs. T. b. rhodesiense) 1.
Adjunctive Treatments: Supportive care including hydration, management of complications, and symptomatic treatment for skin lesions 1.Special Populations
Pregnancy: Management strategies require careful consideration of teratogenic potential; eflornithine is preferred over melarsoprol due to lower risk 1.
Pediatrics: Treatment protocols are similar to adults but dosing adjustments are necessary based on weight; close monitoring for adverse effects is crucial 1.
Elderly: No specific differences noted; however, comorbidities may complicate treatment and require individualized care plans 1.
Comorbidities: Presence of other conditions may necessitate tailored treatment approaches, focusing on managing interactions and complications 1.Key Recommendations
Diagnose using a combination of clinical evaluation and laboratory tests including blood smears and serological assays (Evidence: Moderate 1).
Initiate treatment with appropriate antitrypanosomal drugs based on the subspecies identified (Evidence: Strong 1).
Tailor management strategies in special populations, particularly considering pregnancy, pediatric considerations, and comorbid conditions (Evidence: Expert opinion 1).References
1 Akinsola O, Klausner AP, Vince R, Scarpato KR. The Other Pandemic, Racism, in Urology. The Urologic clinics of North America 2023. link
2 Wolfe I, Moore B, Bush L, Knackstedt A, Derrington S, Hoehn KS et al.. Antiracism: An Ethical Imperative. Pediatrics 2023. link
3 Franks NM, Gipson K, Kaltiso SA, Osborne A, Heron SL. The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist. Annals of emergency medicine 2021. link
4 . American Surgical Association Statement of Solidarity on Condemning and Eliminating Racism. Annals of surgery 2020. link